Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

SC 13G - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G

Filing Date: 2019-07-31

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-07-25

View Filing

424B4 - Prospectus [Rule 424(b)(4)]

Form Type: 424B4

Filing Date: 2019-07-24

View Filing

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2019-07-22

View Filing

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933

Form Type: S-1/A

Filing Date: 2019-07-22

View Filing

CORRESP [Cover] - Correspondence

Form Type: CORRESP

Filing Date: 2019-07-18

View Filing

CORRESP [Cover] - Correspondence

Form Type: CORRESP

Filing Date: 2019-07-18

View Filing

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Form Type: FWP

Filing Date: 2019-07-17

View Filing

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933

Form Type: S-1/A

Filing Date: 2019-07-17

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2019-07-15

View Filing